Golden State Equity Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-200	Closed	-$648	–	776
2024 Q3	$648	Buy	+200	New	+$648	﹤0.01%	776
2022 Q1	$334K	Buy	12,375 +50	+0.4%	+$1.35K	0.17%	142
2021 Q4	$278K	Buy	+12,325	New	+$278K	0.14%	136